Promoting the Development of Traditional Chinese Medicine: Qizheng Tibetan Medicine Leads the New Journey of the Tibetan Medicine Industry with High Quality.

On March 20, the General Office of the State Council officially released the "Opinions on Enhancing the Quality of Traditional Chinese Medicine and Promoting High-Quality Development of the TCM Industry" (hereinafter referred to as the "Opinions"), outlining a blueprint for innovation and upgrading in the TCM sector.

The revitalization of Tibetan medicine is now in full swing. As a pioneer in the modernization of the Tibetan medicine industry, Qizheng Tibetan Medicine is seizing the favorable policy winds and will leverage new-quality productivity to drive innovation and upgrading within the Tibetan medicine sector, leading the industry toward a new stage of high-quality development.

Building a Foundation at the Source: Establishing a Sustainable Supply System for Tibetan Medicinal Herbs

Tibetan medicinal herbs, nurtured in the unique natural environment of the Qinghai-Tibet Plateau, are characterized by their purity, high bioactivity, and remarkable therapeutic efficacy—factors that constitute a key element of Tibetan medicine’s distinctive competitive advantage. Striking a balance between the conservation and sustainable development of these medicinal herbs and building a commercial ecosystem that focuses on long-term benefits is a central issue that Qizheng Tibetan Medicine has been consistently pondering.

Qizheng has established a green and sustainable supply chain. The company has built a database of Tibetan medicinal materials and conducts annual in-depth resource surveys and field studies in the original habitats of these materials, providing precise and scientific evidence for their rational utilization, conservation, and sustainable development. Qizheng actively engages in research on Tibetan medicinal plant cultivation techniques and alternative approaches; it has set up wild-cultivation bases in high-altitude, cold regions and promotes sustainable harvesting practices in the plants’ native areas. As of the end of 2024, the company has conducted cultivation technology research on a total of 58 species, and its various bases—primarily focused on wild-cultivation—cover a combined area of 502,450 mu.

Meanwhile, the company has established and rigorously implemented a supplier sustainability management system, actively collaborating with local farmers, herders, and specialized cooperatives to ensure both the stability of medicinal herb supplies and the maintenance of high-quality standards.

Brand Leadership: Enhancing the Competitiveness of Core Products

Qizheng Tibetan Medicine takes the modernization of Tibetan medicine as its strategic guiding principle and regards the R&D of new products and the secondary development of existing marketed products as key strategic initiatives for the company. It continuously explores advantageous disease categories and therapeutic areas where Tibetan medicine excels, thereby enhancing the clinical efficacy of Tibetan medicines and meeting patients’ health needs.

The company’s current main products include a range of topical formulations centered around pain-relief patches, Qingpeng Ointment, Bai Mai Ointment, and Tie Bang Chui Pain Relief Ointment, as well as oral Tibetan and traditional Chinese medicines such as Honghua Ruyi Pills, Ruyi Zhenbao Tablets, Shiwai Longdan Hua Capsules, Shiwai Longdan Hua Granules, and Renqing Mangjue Capsules. These products cover various therapeutic areas including the musculoskeletal system, nervous system, dermatology, cardiovascular and cerebrovascular health, gynecology, pediatrics, digestive system, respiratory system, and urinary system.

In 2024, the company’s pain-relief plaster received honors including “Annual China Over-the-Counter Drug Golden Best-Selling Product” and “No. 2 in the Comprehensive Statistical Ranking of China’s OTC Products—Traditional Chinese Medicine Category for Bone and Injury Disorders.” The company was also listed on the “2024 Health Industry Brand Value List,” with a brand value of 3.15 billion yuan.

Technology-Driven: Innovation in Tibetan Medicine and Intelligent Manufacturing

Qizheng Tibetan Medicine is consistently committed to transforming millennia-old medical wisdom into clinically proven solutions that can withstand modern scientific validation, leveraging technology to enhance the clinical experience of patients. The company places great importance on evidence-based research and continuously strengthens the evidence-based medical support for its core products—for instance, the company’s flagship product, the Xiaotong Paste, has been backed by tens of thousands of evidence-based studies.

Based on abundant evidence from evidence-based medicine, the company’s products have continuously been included in and recommended by national first-tier academic societies’ guidelines and expert consensuses for both Chinese and Western medicine, providing strong support for precise clinical treatment. In 2024, the company’s products—Baimai Ointment, Qingpeng Ointment, Shiwai Longdan Hua Capsules/Granules, and Honghua Ruyi Pills—were incorporated into several expert consensuses and guidelines, including the “Expert Consensus on Traditional Chinese Medicine Intervention Strategies for Childhood Atopic Dermatitis (Eczema)” and the “Guidelines for Pain Management of Endometriosis (2024 Practice Edition).”

Meanwhile, the company places great importance on digital transformation, intelligent manufacturing, and green production. In 2024, the company’s project, “Smart Factory for Topical Tibetan Medicine Preparations Based on Independently Developed Core Intelligent Equipment,” was included in the first batch of publicly announced “Excellent-Level Smart Factory Projects” by the Ministry of Industry and Information Technology of China.

Qizheng Tibetan Medicine will seize the historic opportunity to build on the millennia-old wisdom of Tibetan medicine while leveraging modern technology to drive industrial upgrading. By pursuing high-quality development, it will lead the Tibetan medicine industry into a new journey and create sustainable value for all stakeholders.

Reporting media: Beijing Youth Net

Report link: https://health.ynet.com/2025/03/24/3877206t3817.html